NASSIM NABBOUT, M.D.
Hematology & Oncology Physician · WICHITA, KS
Individual Active NPI 1528029147
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,353 | 475,168 | $37,820,830 | $11,299,553 | $9,007,406 |
| 2023 | 1,247 | 424,823 | $21,979,701 | $7,969,247 | $6,348,797 |
| 2022 | 975 | 336,797 | $12,910,896 | $6,329,429 | $5,037,928 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 43,300 | $56 | $44 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 41,940 | $0 | $0 |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 33,750 | $1 | $1 |
| J9299 | Injection, nivolumab, 1 mg | 33,420 | $31 | $25 |
| J0185 | Injection, aprepitant, 1 mg | 31,590 | $2 | $1 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 23,440 | $3 | $2 |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 21,600 | $5 | $4 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 17,370 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 14,580 | $50 | $40 |
| J0897 | Injection, denosumab, 1 mg | 12,840 | $25 | $20 |
| J9267 | Injection, paclitaxel, 1 mg | 9,927 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 6,864 | $26 | $21 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 0429749 | KS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Kansas
- NPI 1053372649
- NPI 1841251394
- NPI 1821249137
- NPI 1972721348
- NPI 1043272305
- NPI 1336451665
- NPI 1528263043
- NPI 1750777959
See all Hematology & Oncology Physician providers in Kansas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.